Researchers at the University of Virginia, in collaboration with Manchester, UK-based APIS Assay Technologies Ltd., have discovered Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase is detectable in non-invasive prostate cancer patient samples.
Up to 80% of adolescents and young adults with cancer are affected by reduced fertility after treatment—but only 50% received oncofertility counseling and preservation options prior to beginning treatment.
